The U.S. Food and Drug Administration granted premarket approval for Neurolief's Proliv™Rx neuromodulation system as an adjunctive treatment for major ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE